Health

President Donald Trump signed an executive order seeking to reshape U.S. vaccine policy by recommending that childhood immunizations, specifically the MMR vaccine, be administered as separate single-disease shots during individual medical visits.

The FDA has approved Moderna's first-of-its-kind mRNA flu vaccine for adults aged 50 and older, which aims to improve protection against the virus through faster manufacturing and higher antibody production.

Hospitals are increasingly adopting silicone wristbands to raise awareness of postpartum health risks, even as experts warn that potential Medicaid cuts under the One Big Beautiful Bill Act could threaten the continuity of essential maternal care.

President Donald Trump signed an executive order aimed at reducing the number of recommended childhood vaccines and breaking up the MMR vaccine, a move heavily criticized by medical experts as being unsupported by science.

Two Republican senators have released the first batch of text messages retrieved from Dr. Anthony Fauci’s former government phone as part of an investigation into his leadership and actions during the Covid-19 pandemic – including messages in which he discusses the possible risks and safety of the vaccine during pregnancy.

Vascular surgeon Dr. Xzabia Caliste discussed the importance of recognizing symptoms and seeking early intervention for peripheral artery disease to prevent serious complications like limb amputation.

The FDA proposed a new rule on Monday requiring food manufacturers to notify the agency when using ingredients generally recognized as safe, aiming to close a regulatory loophole highlighted by the Make America Healthy Again movement.

Health officials are investigating multiple clusters of a cyclospora outbreak linked to two deaths and providing guidance on food safety practices to mitigate the spread of the parasite.

The Senate confirmed Dr. Erica Schwartz as the director of the Centers for Disease Control and Prevention, making her the first Black woman to lead the agency amid ongoing concerns regarding political independence.

Fast-fashion giants Shein and Temu face increasing scrutiny over potential health risks from toxic chemicals in their products, even as they dominate the U.S. retail market.